Objective:

To evaluate the effectiveness of a routine invasive strategy versus conservative management in frail patients aged 75 years or older with non–ST-elevation myocardial infarction (NSTEMI).

Key Findings:

• Invasive strategy did not significantly reduce the primary outcome compared to conservative care (38% vs 29%, HR 1.21), indicating no benefit.
• Higher rates of cardiovascular death were observed in the invasive group (26% vs 18%, HR 1.44), suggesting potential harm.
• No reduction in nonfatal myocardial infarction in frail patients (15% vs 14%, HR 1.00), highlighting the ineffectiveness of invasive management.
• Invasive management was associated with more procedural complications (8% in frail patients), raising safety concerns.
• Higher frailty severity correlated with worse outcomes from invasive management, indicating the need for careful assessment.

Interpretation:

The findings suggest that invasive strategies may not provide benefits and could potentially harm frail patients with NSTEMI, indicating the need for careful assessment of frailty severity in treatment decisions.

Limitations:

• Exploratory subgroup design with limited statistical power, affecting the reliability of results.
• Lack of adjustment for multiple comparisons, which may inflate type I error rates.
• Potential residual imbalance due to randomization not being stratified by frailty measure, impacting validity.
• Lower enrollment of patients with advanced frailty may limit generalizability of findings.

Conclusion:

Routine invasive strategies in frail patients with NSTEMI do not yield significant benefits and may pose risks, emphasizing the importance of frailty assessment in treatment planning.